GlassScriptPhysician profile
Ryan D Horazdovsky
NPI 1417196148
$44,152.57
in general payments reported to CMS, 2019-2025
8 companies · $20K in 2025
The $20K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,006 · 2020: $735 · 2021: $1,802 · 2022: $2,496 · 2023: $2,497 · 2024: $16K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Travel and Lodging: $1,630 · Food and Beverage: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,500.00 |
| Travel and Lodging | $1,629.81 |
| Food and Beverage | $982.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anser Implants Holding Bv | $35,500.00 | 2024-2025 | Anser Clavicle Pin |
| Stryker Corporation | $7,183.08 | 2019-2025 | Pro, Mako, Triathlon |
| Gemini Medical LLC | $1,200.00 | 2021 | |
| Kci USA, INC. | $125.00 | 2022 | |
| Depuy Synthes Sales INC. | $82.64 | 2022-2025 | Na |
| The Orthopaedic Implant Company | $40.80 | 2022 | |
| Smith+Nephew, INC. | $14.75 | 2023 | Pico |
| Orthofix Medical, INC. | $6.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$765,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Horazdovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.